Limoneira Co (LMNR) 18.08 $LMNR Limoneira Company

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Limoneira Co (LMNR) 18.08 $LMNR

Limoneira Company Announces Second Quarter Fiscal Year 2016 Financial Results
BusinessWire - Thu Jun 09, 3:05PM CDT
---Company Reiterates Fiscal Year 2016 Guidance Ranges -
LMNR: 18.08 (-0.30)

Limoneira to Announce Second Quarter Fiscal Year 2016 Financial Results on June 9, 2016
BusinessWire - Thu May 26, 7:30AM CDT
Limoneira Company (NASDAQ: LMNR), a leading agribusiness with prime agricultural land and operations, real estate and water rights in California and Arizona, today announced it will release financial results for the second quarter ended April 30, 2016, on Thursday, June 9, 2016, after the market close.
LMNR: 18.08 (-0.30)

Limoneira to Present at the 17th Annual B. Riley & Co. Annual Investor Conference
BusinessWire - Thu May 19, 7:30AM CDT
Limoneira Company (NASDAQ: LMNR), a leading agribusiness with prime agricultural land and operations, real estate and water rights in California and Arizona, today announced that Joe Rumley, the Company's Chief Financial Officer, will be presenting at the 17th Annual B. Riley & Co. Annual Investor Conference, to be held May 25-26, 2016, at The Loews Hollywood Hotel in Los Angeles, California.
LMNR: 18.08 (-0.30)

Limoneira Up 22.1% Since SmarTrend Uptrend Call (LMNR)
Comtex SmarTrend(R) - Wed May 11, 1:45PM CDT
SmarTrend identified an Uptrend for Limoneira (NASDAQ:LMNR) on February 26th, 2016 at $13.78. In approximately 3 months, Limoneira has returned 22.13% as of today's recent price of $16.83.
LMNR: 18.08 (-0.30)

23.9% Return Seen to Date on SmarTrend Limoneira Call (LMNR)
Comtex SmarTrend(R) - Wed May 04, 12:48AM CDT
SmarTrend identified an Uptrend for Limoneira (NASDAQ:LMNR) on February 26th, 2016 at $13.78. In approximately 2 months, Limoneira has returned 23.95% as of today's recent price of $17.08.
LMNR: 18.08 (-0.30)

Limoneira Wins American Planning Association Award for Comprehensive Plan
BusinessWire - Fri Apr 29, 7:30AM CDT
Limoneira Company (the "Company" or "Limoneira" (NASDAQ: LMNR) announced today the Company's Harvest at Limoneira (formerly Santa Paula East Area 1) Project has been awarded the 2016 Comprehensive Plan Award of Excellence from the American Planning Association, California Chapter, Central Coast Section. Limoneira's plan will now move on for consideration in the APA California Chapter state awards this October in Pasadena.
LMNR: 18.08 (-0.30)

Syngenta Downgraded to Hold on Agro-Industry Headwinds
Zacks Equity Research - Zacks Investment Research - Thu Apr 14, 1:45PM CDT
On Apr 13, 2016, Zacks Investment Research downgraded Syngenta AG (SYT) to a Zacks Rank #3 (Hold) from a Zacks Rank #2 (Buy).
SYT: 81.17 (-0.39), LMNR: 18.08 (-0.30), AU: 16.66 (-0.29), AGI: 7.87 (-0.02)

Monsanto (MON) Faces Macro Risks: Dump the Stock Now?
Zacks Equity Research - Zacks Investment Research - Tue Apr 12, 12:55PM CDT
On Apr 11, 2016, we issued an updated research report on premium agro-chemical firm Monsanto Company (MON).
MON: 109.20 (-0.79), SYT: 81.17 (-0.39), LMNR: 18.08 (-0.30), AGI: 7.87 (-0.02)

Limoneira Company Announces Formation of Limoneira South Africa
BusinessWire - Tue Apr 12, 7:30AM CDT
Limoneira Company (the "Company" or "Limoneira" (NASDAQ: LMNR) announced today the formation of Limoneira S.A. (Limoneira South Africa) as another component of the company's One World of Citrus(R) model. Limoneira and South African based Re:inc also announced their partnership called Real Citrus to represent and manage packing and sales opportunities on the continent.
LMNR: 18.08 (-0.30)

Monsanto Misses Q2 Earnings Estimates, Cuts FY16 Guidance
Zacks Equity Research - Zacks Investment Research - Wed Apr 06, 10:02AM CDT
Monsanto Company (MON) reported disappointing results for second-quarter fiscal 2016 (ended Feb 29, 2016).
MON: 109.20 (-0.79), SYT: 81.17 (-0.39), LMNR: 18.08 (-0.30), AGI: 7.87 (-0.02)

Can Limoneira (LMNR) Run Higher on Strong Earnings Estimate Revisions?
Zacks Equity Research - Zacks Investment Research - Tue Apr 05, 7:52AM CDT
Limoneira (LMNR) has decent short-term momentum and it is seeing solid activity on the earnings estimate revision front too.
LMNR: 18.08 (-0.30)

10 Easy Tricks to Green-ify Your Life with Lemons
BusinessWire - Tue Apr 05, 7:30AM CDT
It's no secret that lemons are a boon to any kitchen or DIY beauty routine - but did you know they're a handy sustainability tool as well? With Earth Day around the corner, our Springtime focus is all about making life simpler without investing in potentially toxic chemicals or overpriced tools. We've conferred with our stellar team of opinion leaders to bring you ten great ways you can make your home life a bit more sustainable - with lemons!
LMNR: 18.08 (-0.30)

Limoneira Declares Quarterly Dividend
BusinessWire - Thu Mar 24, 7:30AM CDT
On March 21, 2016, the Board of Directors of Limoneira Company (NASDAQ: LMNR), a leading agribusiness with prime agricultural land and operations, real estate and water rights in California and Arizona, declared a quarterly cash dividend of $0.05 per common share payable on April 15, 2016, to stockholders of record on April 4, 2016.
LMNR: 18.08 (-0.30)

Limoneira reports 1Q loss
Automated Insights - Thu Mar 10, 5:27PM CST
SANTA PAULA, Calif. (AP) _ Limoneira Co. (LMNR) on Thursday reported a loss of $3.9 million in its fiscal first quarter.
LMNR: 18.08 (-0.30)

Limoneira Company Announces First Quarter Fiscal Year 2016 Financial Results
BusinessWire - Thu Mar 10, 3:05PM CST
---Company Raises Fiscal Year 2016 Guidance Range -
LMNR: 18.08 (-0.30)

Limoneira to Present at the 28th Annual ROTH Conference
BusinessWire - Tue Mar 08, 7:30AM CST
Limoneira Company (NASDAQ: LMNR), a leading agribusiness with prime agricultural land and operations, real estate and water rights in California and Arizona, today announced that Harold Edwards, the Company's Chief Executive Officer, and Joe Rumley, the Company's Chief Financial Officer, will be presenting at the 28th Annual ROTH Conference, to be held March 13-16, 2016, at The Ritz-Carlton, Laguna Niguel in Dana Point, California.
LMNR: 18.08 (-0.30)

Limoneira Shares Down 22.4% Since SmarTrend's Sell Call (LMNR)
Comtex SmarTrend(R) - Mon Feb 08, 5:23PM CST
SmarTrend identified a Downtrend for Limoneira (NASDAQ:LMNR) on December 14th, 2015 at $15.31. In approximately 2 months, Limoneira has returned 22.40% as of today's recent price of $11.88.
LMNR: 18.08 (-0.30)

Limoneira Shares Down 17.5% Since SmarTrend's Sell Call (LMNR)
Comtex SmarTrend(R) - Mon Feb 01, 5:06PM CST
SmarTrend identified a Downtrend for Limoneira (NASDAQ:LMNR) on December 14th, 2015 at $15.31. In approximately 2 months, Limoneira has returned 17.50% as of today's recent price of $12.63.
LMNR: 18.08 (-0.30)

DIY Beauty Recipes, Tips and Tricks Using Limoneira Lemons
BusinessWire - Mon Feb 01, 7:30AM CST
Limoneira Company (Nasdaq: LMNR), one of the largest providers of lemons and avocados in the United States, has teamed up with beauty experts from around the country to showcase innovative aesthetic uses for lemons. "When life gives you lemons, take the lemons and unleash some great beauty benefits," says Megan Roosevelt, Limoneira Lemons for Life(TM) Spokesperson and CEO of Healthy Grocery Girl(R). In a new video, Megan shares a number of these tips to put your best face forward.
LMNR: 18.08 (-0.30)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Lauletta Birnbaum Earns Distinction in 2026 Chambers Guide

Updated Category News Views 209

Lauletta Birnbaum Recognized in the 2026 Chambers Spotlight Guide Lauletta Birnbaum has received prestigious recognition in the 2026 Chambers Spotlight Guide in the category of Corporate/Commercial Law. This honor highlights the firm's commitment to providing exceptional legal services to its clients. The Importance of Legal Recognition Chambers and Partners is recognized...

Continue Reading
Medicenna Therapeutics Showcases Advances in Cancer Treatment

Updated Category News Views 127

Medicenna Therapeutics Showcases Advances in Cancer Treatment Medicenna Therapeutics Corp. is making notable strides in the field of cancer immunotherapy. With a focus on developing innovative therapies, the company is gaining attention for its promising Superkines targeting a range of conditions, including cancer. One of their leading programs, MDNA11, has showcased...

Continue Reading
DÉKUPLE Reports Strong Growth in First-Half Earnings 2024

Updated Category News Views 258

DÉKUPLE reported its first-half earnings for 2024, showcasing an 8.8% rise in net sales, totaling €104.6 million. The figures signal a resilient company navigating a turbulent economic backdrop, but traders are already weighing the potential fallout. Key Financial Metrics: Profitability vs. Economic Headwinds The group's gross margin jumped 5.8%, hitting €83.5...

Continue Reading
Main Street Capital Corporation Declares 2025 Dividend Increases

Updated Category News Views 220

Regular Monthly Dividends Announced by Main Street Capital Main Street Capital Corporation (NYSE: MAIN) has taken a significant step forward in announcing its regular monthly dividends for the early part of 2025. The Board of Directors has declared a monthly dividend of $0.25 per share for January, February, and March of that year. This move showcases the company's...

Continue Reading
Exciting New Travel Offers Just for Travelzoo Club Members

Updated Category News Views 306

Exclusive Travel Offers for Club Members Travelzoo® (NASDAQ: TZOO), a leading platform for travel enthusiasts, has rolled out an enticing set of offers tailored specifically for its Club Members. These deals are meticulously negotiated to provide the best experiences at the most competitive prices. Whether you're looking for adventure or relaxation, there's something for...

Continue Reading